<DOC>
	<DOC>NCT02893241</DOC>
	<brief_summary>This is a national, multicentre, prospective, open, two-arm, non-interventional study with hospitalized patients, who are treated routinely with cafedrine/theodrenaline or ephedrine after occurrence of perioperative hypotension, wherein the patients are assigned to a treatment arm based on the department.</brief_summary>
	<brief_title>Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<mesh_term>Theodrenaline</mesh_term>
	<mesh_term>Cafedrine</mesh_term>
	<criteria>Inpatients, who received IV treatment (bolus administration) with cafedrine/theodrenaline or ephedrine (Ephedrin Meduna) due to an acute arterial hypotension Consent to use of data is available Patient under careful blood pressure and pulse monitoring (at least 2 minutes measuring interval (BP/HR) and/or at least 7 measurements within the first 15 minutes after the first application of cafedrine/theodrenaline or ephedrine) Cohort A: Treatment of hypotension in &lt; 100 mm Hg syst. and/or drop in blood pressure &gt; 20% syst. compared to preoperative base value (syst.) Patients ≥ 50 years old Preexisting comorbidities (ASA classification 24) Elective surgery General anaesthesia with propofol/fentanyl ≥ 0.2 mg (or equivalent) Cohort B: Treatment of hypotension in &lt; 100 mm Hg syst. and/or drop in blood pressure &gt; 10% syst. compared to preoperative base value (syst.) Patients ≥ 18 years old Caesarean section under spinal anaesthesia Contraindication to the use of cafedrine/theodrenaline or ephedrine (Ephedrin Meduna) in accordance with current German specialist information Hypersensitivity to any product ingredient Hypertensive blood pressure readings Mitral stenosis Narrowangle glaucoma Hyperthyroidism Pheochromocytoma Prostatic adenoma with urinary retention Bronchial asthmatics with sulphite sensitivity Hyperexcitability Arteriosclerosis Aneurysm Treatment with other indirect sympathomimetic drugs (Example: phenylpropanolamine, phenylephrine, pseudoephedrine or methylphenidate) Use of Monoamine oxidase (MAO) inhibitors (including within the last two weeks) Prophylactic administration of cafedrine/theodrenaline or ephedrine or other antihypertensives Sepsis, septic shock or systemic inflammatory response syndrome (SIRS) Cohort A: • Intracranial surgery or heart surgery Cohort B: Highrisk pregnancy (emergency Caesarean, severe infantile malformation) Multiple pregnancy Amniotic infection syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>